New month – new stocks to add!
Over the last few months, I have been looking at how I can diversify my portfolio and add some strong stocks. Based on the research that I provide for these stocks, you can see why people chose to copy in in their eToro Copy Trader
** If you don’t have an eToro account – you can set one up here! **
** Already have an eToro account? Check out my profile! **
67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.
Note that this does not apply to US Users and eToro USA LLC does not offer CFDs.
In the next few weeks, I’ll be adding the following stocks – reason for choosing them are below. Check out how they are doing on my eToro portfolio
New Stocks
Stock | Sector | Pros | Growth (1yr) |
$BX | Diversified Financials | Strong growth potential, pays a dividend and solid track record. | 14% |
$CBK.DE | Banks | Excellent growth potential, liabilities are made up of primarily low risk sources of funding and pays a dividend | 42% |
$CME | Diversified Financials | Excellent dividend payer, strong balance sheet, the level of debt compared to net worth has been reduced over the past 5 years (13.2% vs 10.7% today) | 15% |
$DB1.DE | Diversified Financials | Established dividend payer, flawless balance sheet, interest on debt is well covered by earnings | 12% |
$FCA.MI | Automobiles | Solid track record and currently undervalued stock price. | 12% |
$GD | Capital Goods | Pays a dividend, great performance history, good value based on earning compared to the US Market | 7% |
$JD.CH | Retail | High growth potential, Total debt is well covered by annual operating cash flow (64.3%, greater than 20% of total debt). | 45% |
$LLOY.L | Banks | Excellent balance sheet, pays a dividend and has a proven track record | 14% |
$MTZ | Capital Goods | Excellent value for money, long tenure of Board of Directors, assets cover its long-term commitments | 10% |
$NTES.CH | Software | Excellent balance sheet, solid performance history, pays a dividend, NetEase earns more interest than it pays | 16% |
$PBYI | Pharmaceutical and Biotech | High growth potential, has no debt, tenure for management team is above average term length | 55% |
$TTWO | Software | Flawless balance sheet with reasonable growth potential and it’s cash and other short-term assets cover its long term commitments. | 76% |
$UNH | Healthcare | Reasonable growth potential, pays a good dividend and a strong history. | 13% |
I’m so happy to read this. This is the kind of manual that needs to be given and not the random misinformation that is at the other blogs. Appreciate your sharing this best doc.